In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

28th European Meeting on Hypertension & Cardiovascular Protection

Prof. Antonio Coca summarises the recent success of the European Meeting on Hypertension & Cardiovascular Protection, held in Barcelona, Spain from 8-11 June 2018



The European Society of Hypertension held its annual meeting in Barcelona on the 8-11 June. More than 2,600 participants from 67 countries and all continents attended the Congress, including 282 speakers and chairpersons, and a very significant participation of delegates from India, China, Japan, the USA, Central America and South America, in addition to Europe and the Middle-East.

A total of 1,145 abstracts were received, of which 178 were accepted for oral presentation in 20 parallel sessions. Of the 863 posters accepted, the 71 judged the best were selected for abbreviated oral presentation during 4 daily one-hour sessions organized according to the different scientific areas.

The largest number of abstracts was on clinical hypertension. In addition to the posters and oral presentations, the programme was structured around the 12 Breakfast Workshops (4 per day), 8 Topical Workshops, 10 Joint Sessions with different Scientific Societies (including a Joint ESH/ESC Session), 3 Teaching Seminars (1 per day), 10 Lectures, 2 Debates, 3 Meet the Expert sessions (1 per day), How-to Sessions, Clinical Case Sessions, and Pre-Congress Teaching Sessions for a selected number of participants and organized by different ESH working groups. In addition to the structured Scientific Programme, several satellite Symposia, Mini-symposia, and Hands-on Sessions were also scheduled.

The Programme covered all current areas of research in the field of hypertension, including basic and clinical research and the main topics of interest for clinicians. Some Joint Sessions were organized to review different clinical and therapeutic aspects of the management of hypertensive patients with Primary Care Physician’s Societies.

2018 ESC/ESH Hypertension Guidelines

In general, all sessions were very well attended but perhaps the most appreciated Session was the preliminary presentation of the new European 2018 ESC/ESH Hypertension Guidelines during the Plenary Session on Saturday 9 June. The content of the Guidelines was summarized by 10 speakers who were the co-authors of the task force that wrote the document in short presentations of approximately 8 minutes on the different aspects including the definition, detection and diagnostic procedures, clinical evaluation, risk stratification, new blood pressure thresholds to start treatment, blood pressure targets to be achieved, lifestyle changes, new therapeutic strategies to better achieve early blood pressure control, follow up of the patient, and gaps in evidence and future studies required.

This presentation was attended by more than 1,700 persons who received the new recommendations very positively, particularly the new stricter targets and the new recommendations on combination therapy in a single pill for most patients with hypertension as the best way to improve the current situation of insufficient blood pressure control worldwide.